James Crowe
Faculty Member
Last active: 3/31/2020

Challenges and opportunities in developing respiratory syncytial virus therapeutics.

Simões EA, DeVincenzo JP, Boeckh M, Bont L, Crowe JE, Griffiths P, Hayden FG, Hodinka RL, Smyth RL, Spencer K, Thirstrup S, Walsh EE, Whitley RJ
J Infect Dis. 2015 211 Suppl 1: S1-S20

PMID: 25713060 · PMCID: PMC4345819 · DOI:10.1093/infdis/jiu828

MeSH Terms (8)

Antiviral Agents Clinical Trials as Topic Drug Approval Drug Discovery Drug Therapy, Combination Humans Respiratory Syncytial Viruses Respiratory Syncytial Virus Infections

Connections (1)

This publication is referenced by other Labnodes entities:

Links